HCWB
HCW Biologics Inc.
NASDAQ · USHealthcareBiotechnology
$3.83-4.25%
Price as of Jul 20, 2026
HCWB capital
HCW Biologics Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 1.14x
- Net debt / equity
- 0.93x
- Debt / assets
- 0.24x
- Debt / EBITDA
- -10.88x
- Net debt / EBITDA
- -8.85x
Liquidity & coverage
- Current ratio
- 0.09x
- Quick ratio
- 0.09x
- Cash ratio
- 0.06x
- Interest coverage
- -13.21x
- EBITDA / interest
- -1.24x
- Working capital
- -$18.2M
Cash & dividend
- FCF / debt
- -1.74x
- Cash flow / debt
- -1.74x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.